4BIO Capital
4BIO Capital invests in early-stage advanced therapy companies, focusing on healthcare. Provides capital, expertise, and guidance to accelerate breakthrough treatments globally.
Funding Stage: Pre-Seed / Seed, Series A/B, Series C & Beyond
Investor type: VC Firm
Investment Areas: Genetics, Beiotech, Gene Therapy, Cell Therapy, RNA-based, Therapy, Targeted Therapies, Microbiome
Country: United Kingdom
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
